FindTrial
Sign In

Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00213122
Enrollment
Unknown
Registered
2005-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2006-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Keywords

alpha-glucosidase inhibitor,Insulin

Brief summary

In this study, the effect of miglitol on daily plasma glucose will be evaluated in type 2 diabetic patients treated with insulin.

Interventions

DRUGmiglitol

Sponsors

Sanwa Kagaku Kenkyusho Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
20 Years to 74 Years
Healthy volunteers
No

Inclusion criteria

* type2 diabetes * postprandial plasma glucose levels ≧180mg/dl

Exclusion criteria

* type1 diabetes * AST(GOT) or ALT(GPT) ≧100IU/l * creatinine ≧2.0mg/dl

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026